ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

342
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
bullish•Insilico Medicine
•13 Sep 2026 15:20

INSILICO: Discovering the Fountain of Youth - You're Not Getting Any Older !!

Insilico Medicine (3696 HK) has risen since its 1H26 earnings announcement.  The company's rentosertib drug reversed biological aging markers in...

Logo
97 Views
Share
•05 Jan 2025 07:30

APAC Healthcare Weekly (Jan 5)- Beigene, Innovent Biologics, CSPC Pharma, Hutchmed, Yuhan, Lupin

APAC healthcare companies got approvals for new products as well as clinical trials. The companies continued with acquisitions and collaborations...

Logo
596 Views
Share
•08 Dec 2024 07:30

APAC Healthcare Weekly (Dec 8)- Eoflow, Celltrion, Takeda, Medipal, SanBio, Aurobindo Pharma

The insight covers key developments in prominent APAC healthcare companies. These developments are expected to impact the financials of the...

Logo
654 Views
Share
•24 Nov 2024 07:30

APAC Healthcare Weekly (Nov 24)- Samsung Biologics, Celltrion, Takeda, Kyowa Kirin, Astellas Pharma

​Samsung Biologics secures new manufacturing deals, Celltrion is acquiring iQone Healthcare, Takeda launches colorectal cancer drug in Japan, and...

Logo
1.2k Views
Share
•03 Nov 2024 07:30

APAC Healthcare Weekly (Nov 3)- Eisai, Takeda, Shionogi, Astellas Pharma, Celltrion, Wuxi AppTec

Large APAC healthcare companies are reporting mixed earnings. Demography will play a key role in ensuring how the overall domestic demand scenario...

Logo
833 Views
Share
x